Hospital-acquired pneumonia in nonintensive care unit wards
To determine the incidence, risk factors, etiology, and antibiotic susceptibility of hospital-acquired pneumonia (HAP) in nonintensive care units (non-ICU) and nonintubated adult patients. Materials and methods: A prospective surveillance study was performed from January 2006 through December 2007 in the medical and surgical wards of the İzmir Teaching and Research Hospital. Results: During the study period, data on 57,133 patients with a total of 413,515 patient-days were analyzed. A total of 106 HAP episodes occurred in 99 patients. The infection rate per 100 patients and per 1000 patient-days was found to be 0.2% and 0.3%, respectively. HAP episodes were detected mostly in medical wards (66%). The mean age of patients was 58.6 ± 15.9 and 73% of the patients were male. The most common intrinsic and extrinsic risk factors observed in patients with HAP, according to the first episode, were cardiovascular disease (47%), central nervous system disease (41%), malignancy (40%), hospitalization longer than 5 days (91%), antibiotic therapy (81%), previous endotracheal intubation (40%), nasogastric tubes (38%), and H2 receptor antagonist/antiacid (37%). Moreover, 109 microorganisms were isolated from 84% of HAP episodes. Overall, the most frequently isolated pathogens from HAP episodes were Klebsiella pneumoniae (23%), Escherichia coli (21%), and Staphylococcus aureus (18%). These were mostly multidrug-resistant. The crude mortality was found to be 25%. Conclusion: Surveillance of HAP in non-ICU and nonintubated adult patients provides valuable guidance for empirical antimicrobial therapy and infection control measures for some wards.
Hospital-acquired pneumonia in nonintensive care unit wards
To determine the incidence, risk factors, etiology, and antibiotic susceptibility of hospital-acquired pneumonia (HAP) in nonintensive care units (non-ICU) and nonintubated adult patients. Materials and methods: A prospective surveillance study was performed from January 2006 through December 2007 in the medical and surgical wards of the İzmir Teaching and Research Hospital. Results: During the study period, data on 57,133 patients with a total of 413,515 patient-days were analyzed. A total of 106 HAP episodes occurred in 99 patients. The infection rate per 100 patients and per 1000 patient-days was found to be 0.2% and 0.3%, respectively. HAP episodes were detected mostly in medical wards (66%). The mean age of patients was 58.6 ± 15.9 and 73% of the patients were male. The most common intrinsic and extrinsic risk factors observed in patients with HAP, according to the first episode, were cardiovascular disease (47%), central nervous system disease (41%), malignancy (40%), hospitalization longer than 5 days (91%), antibiotic therapy (81%), previous endotracheal intubation (40%), nasogastric tubes (38%), and H2 receptor antagonist/antiacid (37%). Moreover, 109 microorganisms were isolated from 84% of HAP episodes. Overall, the most frequently isolated pathogens from HAP episodes were Klebsiella pneumoniae (23%), Escherichia coli (21%), and Staphylococcus aureus (18%). These were mostly multidrug-resistant. The crude mortality was found to be 25%. Conclusion: Surveillance of HAP in non-ICU and nonintubated adult patients provides valuable guidance for empirical antimicrobial therapy and infection control measures for some wards.
___
- American Thoracic Society Documents: Guidelines for the management of adults with hospital-acquired, ventilator- associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
- Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R, Healthcare Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004; 53(RR-3): 1-36. 3. Geyik MF, Hoşoğlu S, Ayaz C, Çelen MK, Üstün C. Surveillance of nosocomial infections in Dicle University Hospital: a ten- year experience. Turk J Med Sci 2008; 38: 587-593.
- Takano Y, Sakamoto O, Suga M, Muranaka H, Ando M. Prognostic factors of nosocomial pneumonia in general wards: a prospective multivariate analysis in Japan. Respir Med 2002; 96: 18-23. 9. Merchant M, Karnad DR, Kanbur AA. Incidence of nosocomial pneumonia in a medical intensive care unit and general medical ward patients in a public hospital in Bombay, India. J Hosp Infect 1998; 39: 143-148.
- Akalın H, Özakın C, Kahveci F, Sütçü Ş, Helvacı S, Gedikoğlu G et al. Hastane kökenli pnömoniler. Flora Dergisi 1999; 4: 253- 257.
- Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128-140.
- Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, 15th Informational Supplement. CLSI Document M 100-S15, Wayne, PA: USA, 2005.
- Karabey S, Ay P. Hastane epidemiyolojisinin temel ilkeleri ve biyoistatistik. In: Doğanay M, Ünal S, editors. Hastane infeksiyonları. 1st ed. Ankara: Bilimsel Tıp Yayınevi; 2003. p.195-223.
- Strausbaugh LJ. Nosocomial respiratory infections. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 6th ed. Philadelphia: Churchill Livingstone; 2005. p.3362-70.
- Bergmans D, Bonten M. Nosocomial pneumonia. In: Mayhall CG, editor. Hospital Epidemiology and Infection Control. Philadelphia. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2004. p.311-39.
- Greenaway CA, Embil J, Orr PH, McLeod J, Dyck B, Nicolle LE. Nosocomial pneumonia on general medical and surgical wards in a tertiary-care hospital. Infect Control Hosp Epidemiol 1997; 18: 749-756.
- Craven DE, Steger KA. Epidemiology of nosocomial pneumonia. New perspectives on an old disease. Chest 1995; 108: 1S-16S.
- Lynch JP 3rd. Hospital-acquired pneumonia: risk factors, microbiology, and treatment. Chest 2001; 119: 373S-384S.
- Weber DJ, Rutala WA, Sickbert-Bennett EE, Samsa GP, Brown V, Niederman MS. Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol 2007; 28: 825-831.
- Lagamayo EN. Antimicrobial resistance in major pathogens of hospital-acquired pneumonia in Asian countries. Am J Infect Control 2008; 36: S101-S108.